- Home
- BCO vs ACLX Comparison
BCO vs ACLX Comparison
Compare BCO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCO
- ACLX
- Stock Information
- Founded
- BCO 1859
- ACLX 2015
- Country
- BCO United States
- ACLX United States
- Employees
- BCO N/A
- ACLX N/A
- Industry
- BCO Oil Refining/Marketing
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- BCO Consumer Discretionary
- ACLX Health Care
- Exchange
- BCO Nasdaq
- ACLX Nasdaq
- Market Cap
- BCO 3.7B
- ACLX 3.8B
- IPO Year
- BCO N/A
- ACLX 2022
- Fundamental
- Price
- BCO $87.59
- ACLX $71.54
- Analyst Decision
- BCO Strong Buy
- ACLX Strong Buy
- Analyst Count
- BCO 1
- ACLX 14
- Target Price
- BCO $138.00
- ACLX $111.42
- AVG Volume (30 Days)
- BCO 201.2K
- ACLX 406.9K
- Earning Date
- BCO 08-06-2025
- ACLX 08-07-2025
- Dividend Yield
- BCO 1.16%
- ACLX N/A
- EPS Growth
- BCO 41.25
- ACLX N/A
- EPS
- BCO 3.72
- ACLX N/A
- Revenue
- BCO $5,022,500,000.00
- ACLX $76,809,000.00
- Revenue This Year
- BCO $3.91
- ACLX N/A
- Revenue Next Year
- BCO $4.45
- ACLX $108.81
- P/E Ratio
- BCO $23.67
- ACLX N/A
- Revenue Growth
- BCO 1.97
- ACLX N/A
- 52 Week Low
- BCO $80.10
- ACLX $47.86
- 52 Week High
- BCO $115.91
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- BCO 37.00
- ACLX 60.36
- Support Level
- BCO $92.59
- ACLX $69.30
- Resistance Level
- BCO $94.55
- ACLX $71.66
- Average True Range (ATR)
- BCO 1.78
- ACLX 2.56
- MACD
- BCO -0.84
- ACLX 0.05
- Stochastic Oscillator
- BCO 4.03
- ACLX 63.46
About BCO Brinks Company (The)
The Brink's Co is a provider of secure logistics and security solutions for cash and other valuables. Its segments include: North America segment includes operations in the U.S. and Canada, including the Brink's Global Services (BGS) line of business; Latin America segment consists operations in Latin American countries where it has an ownership interest, including the BGS line of business; Europe segment includes total operations in European countries that provide services outside of the BGS line of business; and Rest of World segment consists operations in the Middle East, Africa and Asia. It also includes total operations in European countries that provides BGS services and BGS activity in Latin American countries. It derives maximum revenue from North America segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.